Uterine clear cell carcinoma

Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus
Julian C. Hong, Jonathan Foote, Gloria Broadwater, Stéphanie Gaillard, Laura J. Havrilesky, Junzo P. Chino

International Journal of Gynecologic Cancer May 2017, 27 (4) 720-729; DOI: 10.1097/IGC.0000000000000926
Utilization and Role of Adjuvant Radiotherapy and Chemotherapy for Uterine Clear Cell Carcinoma: A National Cancer Data Base Analysis
Karen M. Xu, Beant S. Gill, Goundappa K. Balasubramani, Paniti Sukumvanich, Joseph L. Kelley, Sushil Beriwal

International Journal of Gynecologic Cancer Mar 2016, 26 (3) 472-482; DOI: 10.1097/IGC.0000000000000640
Racial Disparities in Uterine Clear Cell Carcinoma: A Multi-Institution Study
Zaid R. Al-Wahab, Sanjeev Kumar, David G. Mutch, Sean C. Dowdy, Sharon A. Hensley, Yun Wang, Hidar Mahdi, Rouba Ali-Fehmi, Robert T. Morris, Mohammed Elshaikh, Adnan R. Munkarah

International Journal of Gynecologic Cancer Mar 2014, 24 (3) 541-548; DOI: 10.1097/IGC.0000000000000068
Combined Chemotherapy Regimen of Carboplatin and Paclitaxel as Adjuvant Treatment for Papillary Serous and Clear Cell Endometrial Cancer
Gil Shechter-Maor, Ilan Bruchim, Zipi Ben-Harim, Marco Altaras, Ami Fishman

International Journal of Gynecologic Cancer Apr 2009, 19 (4) 662-664; DOI: 10.1111/IGC.0b013e3181a3d626

Main menu